RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Alzheimer's Drug Discovery Foundation
A

Alzheimer's Drug Discovery Foundation portfolio

Alzheimer's Drug Discovery Foundation has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $15M.
Latest deal: Circular Genomics · Dec 1, 2025.
About this page

Its most recent investment on record is Circular Genomics's $15M Series A round in December 2025, alongside Poplar Grove Investors, Mountain Group Capital and HIP. By category, its portfolio leans toward Health and bio (2).

What Alzheimer's Drug Discovery Foundation invests in

How Alzheimer's Drug Discovery Foundation invests

StageDealsCapital in rounds
Series A 1 100%$15M

Alzheimer's Drug Discovery Foundation portfolio companies

CompanyRound with Alzheimer's Drug Discovery FoundationTotal raisedLatest raise
CCircular Genomics
Health and bio
Series A · $15M$27.8MDec 1, 2025
Series A
CC. Light Technologi
Health and bio
backerundisclosed—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Alzheimer's Drug Discovery Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Alzheimer's Drug Discovery Foundation, which is a subset of its real portfolio. API: /api/v1/investors/alzheimer-s-drug-discovery-foundation (get a free API key). More: the most active VC firms and new venture capital funds.